Dr. Peter Merkel delivers a high-level overview of the types of clinical research studies into vasculitis. He covers such studies as PEXIVAS, ADVOCATE (Avacopan), and Tocilizumab in Giant Cell Artertis. Moreover, Dr. Merkel discusses some of the unmet and needs and challenges facing researchers. Finally, he talks about why vasculitis research is dependent on the participation of patients.
Peter A. Merkel, MD
Professor of Medicine and Epidemiology
Chief, Division of Rheumatology
University of Pennsylvania